INTRODUCTION OF ANTI-TUMOR T LYMPHOCYTES IN HUMAN USING PEPTIDE EPITOPES FOUND BY COMPUTER BASED ALGORITHMS FOR VACCINATION

Details for Australian Patent Application No. 2002257647 (hide)

Owner CALLISTOGEN AG

Inventors WREDE, Paul; WALDEN, Peter; EICHLER-MERTENS, Mathias; FILTER, Matthias

Pub. Number AU-A-2002257647

PCT Pub. Number WO2002/072627

Priority 60/274,250 09.03.01 US; 60/290,353 14.05.01 US; 60/291,610 18.05.01 US

Filing date 11 March 2002

Wipo publication date 24 September 2002

International Classifications

C07K 014/47 Peptides having more than 20 amino acids

A61K 039/00 Medicinal preparations containing antigens or antibodies

A61P 035/00 Antineoplastic agents

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

G06F 019/00 Digital computing or data processing equipment or methods, specially adapted for specific applications

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-A-2002257647

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002257648-CD4+CD25+ regulatory T cells from human blood

2002257646-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND USES IN THERAPY (5HT1B RECEPTOR ACTIVITY)